COHERUS BIOSCIENCES I
1.2600
27-November-24 16:45:00
15 minutes delayed
Stocks
-0.0200
-1.56%
Today's range
1.2300 - 1.3500
ISIN
N/A
Source
NASDAQ
-
05 Oct 2023 08:30:00 By Nasdaq GlobeNewswire
-
CIMERLI® (ranibizumab-eqrn) Sales Exceed 100,000 Doses in First Year of Launch
04 Oct 2023 08:30:00 By Nasdaq GlobeNewswire
-
Coherus Applauds Congressional Designation of September 30th as Rare Cancer Day
02 Oct 2023 09:00:00 By Nasdaq GlobeNewswire
-
27 Sep 2023 09:10:29 By Nasdaq GlobeNewswire
-
Coherus BioSciences Announces New Employment Inducement Grants
22 Sep 2023 21:00:00 By Nasdaq GlobeNewswire
-
Coherus Completes Surface Oncology Acquisition
08 Sep 2023 09:05:40 By Nasdaq GlobeNewswire
-
Coherus BioSciences to Participate at Upcoming September Investor Conferences
01 Sep 2023 16:01:00 By Nasdaq GlobeNewswire
-
Coherus BioSciences Announces New Employment Inducement Grants
22 Aug 2023 17:35:22 By Nasdaq GlobeNewswire
-
Coherus BioSciences Reports Second Quarter 2023 Financial Results and Business Highlights
02 Aug 2023 16:01:00 By Nasdaq GlobeNewswire
-
Coherus BioSciences to Report Second Quarter 2023 Financial Results on August 02, 2023
26 Jul 2023 16:05:00 By Nasdaq GlobeNewswire
-
Coherus BioSciences Announces New Employment Inducement Grants
21 Jul 2023 17:30:00 By Nasdaq GlobeNewswire
-
Coherus BioSciences Appoints Dr. Michael Ryan to its Board of Directors
20 Jul 2023 16:04:53 By Nasdaq GlobeNewswire
-
Coherus and Superior Biologics Announce National Distribution Agreement for YUSIMRY™
13 Jul 2023 08:30:00 By Nasdaq GlobeNewswire
-
Coherus Launches YUSIMRY™, a Biosimilar of Humira®, at $995 per Carton in U.S.
03 Jul 2023 08:30:00 By Nasdaq GlobeNewswire
-
Coherus BioSciences Announces New Employment Inducement Grants
26 Jun 2023 21:08:00 By Nasdaq GlobeNewswire
-
Coherus to Acquire Surface Oncology
16 Jun 2023 07:01:00 By Nasdaq GlobeNewswire
-
05 Jun 2023 17:30:00 By Nasdaq GlobeNewswire
-
01 Jun 2023 08:33:07 By Nasdaq GlobeNewswire
-
01 Jun 2023 08:30:00 By Nasdaq GlobeNewswire